Real-World Effectiveness of Biologic Disease-Modifying Antirheumatic Drugs for the Treatment of Rheumatoid Arthritis After Etanercept Discontinuation in the United Kingdom, France, and Germany

Clinical Therapeutics - United States
doi 10.1016/j.clinthera.2017.06.009
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Elsevier BV

Related search

Predictors of Stopping and Starting Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis

Arthritis Care and Research
Rheumatology
2014English

Assessing the Effectiveness of Synthetic and Biologic Disease-Modifying Antirheumatic Drugs in Psoriatic Arthritis &Ndash; A Systematic Review

Psoriasis: Targets and Therapy
DermatologyRheumatology
2015English

Changes in Use of Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis in the United States During 1983-2009

Arthritis Care and Research
Rheumatology
2013English

Association of Seropositivity and Mortality in Rheumatoid Arthritis and the Impact of Treatment With Disease‐Modifying Antirheumatic Drugs

Arthritis Care and Research
Rheumatology
2020English

Lipid Profiles in Rheumatoid Arthritis Patients Treated With Disease-Modifying Antirheumatic Drugs

Reumatologia
RheumatologyAllergyImmunology
2014English

High Incidence of Disease Recurrence After Discontinuation of Disease-Modifying Antirheumatic Drug Treatment in Patients With Psoriatic Arthritis in Remission

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2013English

Comparative Effectiveness of Tocilizumab Versus TNF Inhibitors as Monotherapy or in Combination With Conventional Synthetic Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis After the Use of at Least One Biologic Disease-Modifying Antirheumatic Drug: Analyses From the Pan-European TOCERRA Register Collaboration

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2018English

Safety of Abatacept Compared With Other Biologic and Conventional Synthetic Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis: Data From an Observational Study

Arthritis Research & Therapy
2019English

FRI0754-HPR Impact of Corticosteroid Utilization on Biologic Disease-Modifying Antirheumatic Drug Initiation Among Patients With Rheumatoid Arthritis

2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy